Anita Difrancesco

Suggest Changes
Learn More
PURPOSE Expansion and activation of natural killer (NK) cells with interleukin-2 (IL-2) may enhance antibody-dependent cellular cytotoxicity (ADCC), an important mechanism of rituximab activity. Two(More)
  • 1